Novartis to Acquire Gyroscope Therapeutics, Netting a Fast-Tracked Ocular Gene Therapy

Novartis announced that it will acquire the UK-based ocular gene therapy company Gyroscope Therapeutics, giving Novartis a one-time gene therapy for geographic atrophy (GA), a leading cause of blindness.
Source: Drug Industry Daily